Javascript must be enabled to continue!
Influence of Chronic Renal Failure on Stereoselective Metoprolol Metabolism in Hypertensive Patients
View through CrossRef
The influence of chronic renal failure on the stereoselective metabolism of rac‐metoprolol was investigated in 15 hypertensive patients, 7 of them with chronic renal failure and 8 with normal renal function. They were treated with rac‐metoprolol (200 mg) for 7 days. The patients of both groups presented stereoselectivity in metoprolol metabolism, favoring the formation of 1'R‐α‐hydroxymetoprolol (AUC0–241'R/1'S ≅ 2.5) and (R)‐metoprolol acidic metabolite (AUC(S)/(R)0–24 ≅ 0.8), the latter resulting in the plasma accumulation of (S)‐metoprolol (AUC(S)/(R)0–24 ≅ 1.2). Patients with chronic renal failure presented plasma accumulation of the 4 α‐hydroxymetoprolol isomers and of both metoprolol acidic metabolite enantiomers. A 50% reduction in ClR does not explain the 3‐ to 4‐fold plasma accumulation of metoprolol acidic metabolite in this group, suggesting that other pathways of metoprolol elimination are affected in chronic renal failure in addition to renal excretion. Chronic renal failure does not change the stereoselective kinetic disposition of metoprolol but modifies its stereoselective metabolism, inducing some of the CYP enzymes involved in the formation of the metoprolol acid metabolite.
Title: Influence of Chronic Renal Failure on Stereoselective Metoprolol Metabolism in Hypertensive Patients
Description:
The influence of chronic renal failure on the stereoselective metabolism of rac‐metoprolol was investigated in 15 hypertensive patients, 7 of them with chronic renal failure and 8 with normal renal function.
They were treated with rac‐metoprolol (200 mg) for 7 days.
The patients of both groups presented stereoselectivity in metoprolol metabolism, favoring the formation of 1'R‐α‐hydroxymetoprolol (AUC0–241'R/1'S ≅ 2.
5) and (R)‐metoprolol acidic metabolite (AUC(S)/(R)0–24 ≅ 0.
8), the latter resulting in the plasma accumulation of (S)‐metoprolol (AUC(S)/(R)0–24 ≅ 1.
2).
Patients with chronic renal failure presented plasma accumulation of the 4 α‐hydroxymetoprolol isomers and of both metoprolol acidic metabolite enantiomers.
A 50% reduction in ClR does not explain the 3‐ to 4‐fold plasma accumulation of metoprolol acidic metabolite in this group, suggesting that other pathways of metoprolol elimination are affected in chronic renal failure in addition to renal excretion.
Chronic renal failure does not change the stereoselective kinetic disposition of metoprolol but modifies its stereoselective metabolism, inducing some of the CYP enzymes involved in the formation of the metoprolol acid metabolite.
Related Results
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
BackgroundA clinical dilemma exists in patients with CKD, ESKD, and after kidney transplantation, as they face concurrent risks of both thromboembolic and hemorrhagic complications...
e0680 Relationship between polymorphism of ACE and the curative effect of metoprolol on chronic heart failure
e0680 Relationship between polymorphism of ACE and the curative effect of metoprolol on chronic heart failure
Objective
To investigate the effect of metoprolol on chronic heart failure and to discuss the relationship between polymorphism of ACE and the curative effect of ...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Differing Beta-Blocking Effects of Carvedilol and Metoprolol
Differing Beta-Blocking Effects of Carvedilol and Metoprolol
Abstract
Background
Metoprolol is a beta1-selective beta-adrenergic antagonist while carvedilol is a non-selective beta-b...
ASSA13-14-12 Association of Renal Artery Variations and Renal Artery Stenosis, Impaired Renal Function, Plasma Renin Activity
ASSA13-14-12 Association of Renal Artery Variations and Renal Artery Stenosis, Impaired Renal Function, Plasma Renin Activity
Objectives
To compare the prevalence of hemodynamically significant stenosis between renal arteries with and without variations in resistant hypertensive patients...
HYPERTENSIVE CRISES: HYPERTENSIVE EMERGENCY AND CRISIS MANAGEMENT DURING ANESTHESIA
HYPERTENSIVE CRISES: HYPERTENSIVE EMERGENCY AND CRISIS MANAGEMENT DURING ANESTHESIA
Introduction: hypertensive crisis is characterized by an acute and massive increase in blood pressure. Hypertensive crises encompass several clinical situations with different seve...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...

